Date: June 14, 2023
Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST)
Influenza is a highly contagious respiratory illness that affects millions of people worldwide each year. The influenza virus is constantly evolving, making it difficult to predict and prevent outbreaks. Current influenza vaccines come in various types, including live attenuated virus vaccines, inactivated whole virus vaccines, virosome vaccines, split-virion vaccines, and subunit vaccines. However, they have certain limitations, such as high manufacturing costs, prolonged production time, moderate effectiveness among specific groups, and limited cross-reactivity. This webinar outlines recent advancements in the development and use of different types of influenza vaccines, as well as future directions, such as creating universal influenza vaccines. Furthermore, the immune response is a critical factor in evaluating the vaccine's efficacy and side effects, and it is measured by detecting cytokines such as IFN-α, IL-6, and G-CSF. The association between cytokine production and influenza vaccine antibody response will also be discussed. Sino Biological offers the world's largest collection of influenza bioreagents to support influenza research.
- Overview of the impact of Influenza A and B viruses on global health
- Outline current strategies and recent advances in the development and application of influenza vaccines
- Introduction of cytokine release in response to influenza vaccine
- Discuss challenges and future directions for influenza vaccine research and development
Webinars will be available for unlimited on-demand viewing after live event.
Labroots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.